Cargando…

Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis

Objective. The multibiomarker disease activity (MBDA) blood test has been clinically validated as a measure of disease activity in patients with RA. We aimed to estimate the effect of the MBDA test on physical function for patients with RA (based on HAQ), quality-adjusted life years and costs over 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michaud, Kaleb, Strand, Vibeke, Shadick, Nancy A., Degtiar, Irina, Ford, Kerri, Michalopoulos, Steven N., Hornberger, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536857/ https://www.ncbi.nlm.nih.gov/pubmed/25877911 http://dx.doi.org/10.1093/rheumatology/kev023

Ejemplares similares

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
por: Curtis, Jeffrey R, et al.
Publicado: (2012)

Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia
por: Lee, Yvonne C., et al.
Publicado: (2016)

Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis
por: Kay, Jonathan, et al.
Publicado: (2022)

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
por: Rech, Juergen, et al.
Publicado: (2016)

Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis
por: Meznerics, Fanni A, et al.
Publicado: (2022)

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial
por: Hambardzumyan, Karen, et al.
Publicado: (2016)

Use of electroporation and reverse iontophoresis for extraction of transdermal multibiomarkers
por: Ching, Congo Tak-Shing, et al.
Publicado: (2012)

Using technology to support clinical care and research in rheumatoid arthritis
por: Dixon, William G., et al.
Publicado: (2018)

Impact of Rheumatoid Arthritis Disease Activity Test on Clinical Practice
por: Peabody, John W., et al.
Publicado: (2013)

The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study
por: Wolfe, Frederick, et al.
Publicado: (2010)

A Mobile App With Optical Imaging for the Self-Management of Hand Rheumatoid Arthritis: Pilot Study
por: Mollard, Elizabeth, et al.
Publicado: (2018)

Randomized controlled trial design in rheumatoid arthritis: the past decade
por: Strand, Vibeke, et al.
Publicado: (2009)

The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis
por: Hernández Alava, Mónica, et al.
Publicado: (2013)

The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis
por: Shafrin, Jason, et al.
Publicado: (2018)

LC-MS/MS-based multibiomarker approaches for the assessment of human exposure to mycotoxins
por: Warth, Benedikt, et al.
Publicado: (2013)

Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs
por: Patel, Vardhaman, et al.
Publicado: (2022)

Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
por: Fournier, Marie, et al.
Publicado: (2019)

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
por: Ogdie, Alexis, et al.
Publicado: (2022)

Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
por: Ozen, Gulsen, et al.
Publicado: (2021)

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study
por: Ogdie, Alexis, et al.
Publicado: (2023)

Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis
por: Strand, Vibeke, et al.
Publicado: (2018)

Meaning of patient global assessment when joint counts are low in rheumatoid arthritis
por: Felson, David, et al.
Publicado: (2022)

Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry
por: Shadick, Nancy, et al.
Publicado: (2023)

Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects
por: Smith, Christopher J, et al.
Publicado: (2011)

Data for the analysis of interactive multibiomarker responses of a marine crustacean to long-term exposure to aquatic contaminants
por: Abreu, Isabel Oliveira, et al.
Publicado: (2018)

Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
por: Ramiro, Sofia, et al.
Publicado: (2015)

Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs
por: Ozen, Gulsen, et al.
Publicado: (2019)

Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
por: Centola, Michael, et al.
Publicado: (2013)

Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
por: Ruderman, Eric M., et al.
Publicado: (2012)

Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
por: Cannon, Grant W., et al.
Publicado: (2016)

Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study
por: Alemao, Evo, et al.
Publicado: (2020)

Latent profile analysis approach to the relationship between patient and physician global assessments of rheumatoid arthritis activity
por: Karpouzas, George A, et al.
Publicado: (2018)

Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient‐Reported Outcomes Measurement Information System Pain Interference Short Form in Rheumatoid Arthritis
por: Katz, Patricia, et al.
Publicado: (2020)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study
por: Ozen, Gulsen, et al.
Publicado: (2019)

Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis
por: Desilet, Luke W., et al.
Publicado: (2020)

Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty
por: Michaud, Kaleb, et al.
Publicado: (2013)

Health care utilization and costs associated with functional status in patients with psoriatic arthritis
por: Ogdie, Alexis, et al.
Publicado: (2022)

A Multibiomarker Approach to Assess the Health State of Coastal Ecosystem Receiving Desalination Plants in Agadir Bay, Morocco
por: Elazzaoui, Ahmed, et al.
Publicado: (2019)

Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis
por: Curtis, Jeffrey R, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bdlgb5ip4srefrb5pufor2tqam